Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc., trading under the ticker LACQ, filed a Form 10-Q with the SEC on August 7, 2019, reflecting its active reporting status during that period as a SPAC operating in the life sciences and pharmaceutical sector. The company's focus on biosciences positioned it within the healthcare-oriented segment of the blank-check vehicle universe, which saw heightened activity heading into the 2020 SPAC boom. The filing, assigned accession number 0001213900-19-014824, represents a standard quarterly disclosure of financial condition and operational activity. For the complete filing history, deal timeline, and sponsor details on LACQ, sign up for full data access at SpacDesk.